|
1
|
Mizrahi JD, Surana R, Valle JW and Shroff
RT: Pancreatic cancer. Lancet. 395:2008–2020. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martin-Perez E, Domínguez-Muñoz JE,
Botella-Romero F, Cerezo L, Matute Teresa F, Serrano T and Vera R:
Multidisciplinary consensus statement on the clinical management of
patients with pancreatic cancer. Clin Transl Oncol. 22:1963–1975.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zaccara S, Ries RJ and Jaffrey SR:
Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell
Biol. 20:608–624. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fu Y, Dominissini D, Rechavi G and He C:
Gene expression regulation mediated through reversible
m6A RNA methylation. Nat Rev Genet. 15:293–306. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Z, Lv J, Yu H, Han J, Yang X, Feng D,
Wu Q, Yuan B, Lu Q and Yang H: Mechanism of RNA modification
N6-methyladenosine in human cancer. Mol Cancer. 19:1042020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He L, Li H, Wu A, Peng Y, Shu G and Yin G:
Functions of N6-methyladenosine and its role in cancer. Mol Cancer.
18:1762019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frye M, Harada BT, Behm M and He C: RNA
modifications modulate gene expression during development. Science.
361:1346–1349. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun T, Wu R and Ming L: The role of m6A
RNA methylation in cancer. Biomed Pharmacother. 112:1086132019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen XY, Zhang J and Zhu JS: The role of
m6A RNA methylation in human cancer. Mol Cancer.
18:1032019. View Article : Google Scholar
|
|
10
|
Lan Q, Liu PY, Haase J, Bell JL,
Huttelmaier S and Liu T: The critical role of RNA m6A
methylation in cancer. Cancer Res. 79:1285–1292. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei CM, Gershowitz A and Moss B:
Methylated nucleotides block 5′ terminus of HeLa cell messenger
RNA. Cell. 4:379–386. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rottman F, Shatkin AJ and Perry RP:
Sequences containing methylated nucleotides at the 5′ termini of
messenger RNAs: Possible implications for processing. Cell.
3:197–199. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Desrosiers R, Friderici K and Rottman F:
Identification of methylated nucleosides in messenger RNA from
Novikoff hepatoma cells. Proc Natl Acad Sci USA. 71:3971–3975.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adams JM and Cory S: Modified nucleosides
and bizarre 5′-termini in mouse myeloma mRNA. Nature. 255:28–33.
1975. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schäfer KP: RNA synthesis and processing
reactions in a subcellular system from mouse L cells. Hoppe Seylers
Z Physiol Chem. 363:33–43. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bokar JA, Shambaugh ME, Polayes D, Matera
AG and Rottman FM: Purification and cDNA cloning of the
AdoMet-binding subunit of the human mRNA
(N6-adenosine)-methyltransferase. RNA. 3:1233–1247. 1997.PubMed/NCBI
|
|
17
|
Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang
Y, Yi C, Lindahl T, Pan T, Yang YG and He C: N6-methyladenosine in
nuclear RNA is a major substrate of the obesity-associated FTO. Nat
Chem Biol. 7:885–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meyer KD, Saletore Y, Zumbo P, Elemento O,
Mason CE and Jaffrey SR: Comprehensive analysis of mRNA methylation
reveals enrichment in 3′ UTRs and near stop codons. Cell.
149:1635–1646. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schibler U, Kelley DE and Perry RP:
Comparison of methylated sequences in messenger RNA and
heterogeneous nuclear RNA from mouse L cells. J Mol Biol.
115:695–714. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rottman FM, Desrosiers RC and Friderici K:
Nucleotide methylation patterns in eukaryotic mRNA. Prog Nucleic
Acid Res Mol Biol. 19:21–38. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei CM and Moss B: Nucleotide sequences at
the N6-methyladenosine sites of HeLa cell messenger ribonucleic
acid. Biochemistry. 16:1672–1676. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Krug RM: Influenza viral mRNA contains
internal N6-methyladenosine and 5′-terminal 7-methyl-guanosine in
cap structures. J Virol. 20:45–53. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Beemon K and Keith J: Localization of
N6-methyladenosine in the rous sarcoma viru genome. J Mol Bid.
113:165–179. 1977. View Article : Google Scholar
|
|
24
|
Dominissini D, Moshitch-Moshkovitz S,
Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K,
Jacob-Hirsch J, Amariglio N, Kupiec M, et al: Topology of the human
and mouse m6A RNA methylomes revealed by m6A-seq. Nature.
485:201–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schwartz S, Mumbach MR, Jovanovic M, Wang
T, Maciag K, Bushkin GG, Mertins P, Ter-Ovanesyan D, Habib N,
Cacchiarelli D, et al: Perturbation of m6A writers reveals two
distinct classes of mRNA methylation at internal and 5′ sites. Cell
Rep. 8:284–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Geula S, Moshitch-Moshkovitz S,
Dominissini D, Mansour AA, Kol N, Salmon-Divon M, Hershkovitz V,
Peer E, Mor N, Manor YS, et al: Stem cells. m6A mRNA methylation
facilitates resolution of naïve pluripotency toward
differentiation. Science. 347:1002–1006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma H, Wang X, Cai J, Dai Q, Natchiar SK,
Lv R, Chen K, Lu Z, Chen H, Shi YG, et al:
N6-methyladenosine methyltransferase ZCCHC4 mediates
ribosomal RNA methylation. Nat Chem Biol. 15:88–94. 2019.
View Article : Google Scholar
|
|
28
|
van Tran N, Ernst FGM, Hawley BR, Zorbas
C, Ulryck N, Hackert P, Bohnsack KE, Bohnsack MT, Jaffrey SR,
Graille M and Lafontaine DLJ: The human 18S rRNA m6A
methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids
Res. 47:7719–7733. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ueda Y, Ooshio I, Fusamae Y, Kitae K,
Kawaguchi M, Jingushi K, Hase H, Harada K, Hirata K and Tsujikawa
K: AlkB homolog 3-mediated tRNA demethylation promotes protein
synthesis in cancer cells. Sci Rep. 7:422712017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo H, Zhu G, Xu J, Lai Q, Yan B, Guo Y,
Fung TK, Zeisig BB, Cui Y, Zha J, et al: HOTTIP lncRNA promotes
hematopoietic stem cell self-renewal leading to AML-like disease in
mice. Cancer Cell. 36:645–659.e8. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng ZQ, Li ZX, Zhou GQ, Lin L, Zhang LL,
Lv JW, Huang XD, Liu RQ, Chen F, He XJ, et al: Long noncoding RNA
FAM225A promotes nasopharyngeal carcinoma tumorigenesis and
metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and
upregulate ITGB3. Cancer Res. 79:4612–4626. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cesarini V, Silvestris DA, Tassinari V,
Tomaselli S, Alon S, Eisenberg E, Locatelli F and Gallo A:
ADAR2/miR-589-3p axis controls glioblastoma cell
migration/invasion. Nucleic Acids Res. 46:2045–2059. 2018.
View Article : Google Scholar :
|
|
33
|
Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu
HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, et al: METTL3 promote tumor
proliferation of bladder cancer by accelerating pri-miR221/222
maturation in m6A-dependent manner. Mol Cancer. 18:1102019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li J, Huang C, Zou Y, Ye J, Yu J and Gui
Y: CircTLK1 promotes the proliferation and metastasis of renal cell
carcinoma by sponging miR-136-5p. Mol Cancer. 19:1032020.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pendleton KE, Chen B, Liu K, Hunter OV,
Xie Y, Tu BP and Conrad NK: The U6 snRNA m6A
methyltransferase METTL16 regulates SAM synthetase intron
retention. Cell. 169:824–835.e14. 2017. View Article : Google Scholar
|
|
36
|
Roundtree IA, Evans ME, Pan T and He C:
Dynamic RNA modifications in gene expression regulation. Cell.
169:1187–1200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Linder B, Grozhik AV, Olarerin-George AO,
Meydan C, Mason CE and Jaffrey SR: Single-nucleotide-resolution
mapping of m6A and m6Am throughout the transcriptome. Nat Methods.
12:767–772. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Horiuchi K, Kawamura T, Iwanari H, Ohashi
R, Naito M, Kodama T and Hamakubo T: Identification of Wilms' tumor
1-associating protein complex and its role in alternative splicing
and the cell cycle. J Biol Chem. 288:33292–33302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Narayan P and Rottman FM: An in vitro
system for accurate methylation of internal adenosine residues in
messenger RNA. Science. 242:1159–1162. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Schumann U, Shafik A and Preiss T: METTL3
gains R/W access to the epitranscriptome. Mol Cell. 62:323–324.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Śledź P and Jinek M: Structural insights
into the molecular mechanism of the m(6)A writer complex. Elife.
5:e184342016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang P, Doxtader KA and Nam Y: Structural
basis for cooperative function of Mettl3 and Mettl14
methyltransferases. Mol Cell. 63:306–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang
L, Jia G, Yu M, Lu Z, Deng X, et al: A METTL3-METTL14 complex
mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem
Biol. 10:93–95. 2014. View Article : Google Scholar :
|
|
44
|
Wang X, Feng J, Xue Y, Guan Z, Zhang D,
Liu Z, Gong Z, Wang Q, Huang J, Tang C, et al: Corrigendum:
Structural basis of N6-adenosine methylation by the METTL3-METTL14
complex. Nature. 542:2602017. View Article : Google Scholar
|
|
45
|
Ping XL, Sun BF, Wang L, Xiao W, Yang X,
Wang WJ, Adhikari S, Shi Y, Lv Y, Chen YS, et al: Mammalian WTAP is
a regulatory subunit of the RNA N6-methyladenosine
methyltransferase. Cell Res. 24:177–189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Schöller E, Weichmann F, Treiber T, Ringle
S, Treiber N, Flatley A, Feederle R, Bruckmann A and Meister G:
Interactions, localization, and phosphorylation of the m6A
generating METTL3-METTL14-WTAP complex. RNA. 24:499–512. 2018.
View Article : Google Scholar
|
|
47
|
Yue Y, Liu J, Cui X, Cao J, Luo G, Zhang
Z, Cheng T, Gao M, Shu X, Ma H, et al: VIRMA mediates preferential
m6A mRNA methylation in 3′UTR and near stop codon and
associates with alternative polyadenylation. Cell Discov. 4:102018.
View Article : Google Scholar
|
|
48
|
Patil DP, Chen CK, Pickering BF, Chow A,
Jackson C, Guttman M and Jaffrey SR: m(6)A RNA methylation promotes
XIST-mediated transcriptional repression. Nature. 537:369–373.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Knuckles P, Lence T, Haussmann IU, Jacob
D, Kreim N, Carl SH, Masiello I, Hares T, Villaseñor R, Hess D, et
al: Zc3h13/Flacc is required for adenosine methylation by bridging
the mRNA-binding factor Rbm15/Spenito to the m6A machinery
component Wtap/Fl(2)d. Genes Dev. 32:415–429. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wen J, Lv R, Ma H, Shen H, He C, Wang J,
Jiao F, Liu H, Yang P, Tan L, et al: Zc3h13 regulates nuclear RNA
m6A methylation and mouse embryonic stem cell
self-renewal. Mol Cell. 69:1028–1038.e6. 2018. View Article : Google Scholar
|
|
51
|
Fujita Y, Krause G, Scheffner M, Zechner
D, Leddy HE, Behrens J, Sommer T and Birchmeier W: Hakai, a
c-Cbl-like protein, ubiquitinates and induces endocytosis of the
E-cadherin complex. Nat Cell Biol. 4:222–231. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bawankar P, Lence T, Paolantoni C,
Haussmann IU, Kazlauskiene M, Jacob D, Heidelberger JB, Richter FM,
Nallasivan MP, Morin V, et al: Hakai is required for stabilization
of core components of the m6A mRNA methylation
machinery. Nat Commun. 12:37782021. View Article : Google Scholar
|
|
53
|
Wei J, Liu F, Lu Z, Fei Q, Ai Y, He PC,
Shi H, Cui X, Su R, Klungland A, et al: Differential
m6A, m6Am, and m1A demethylation
mediated by FTO in the cell nucleus and cytoplasm. Mol Cell.
71:973–985.e5. 2018. View Article : Google Scholar
|
|
54
|
Zheng G, Dahl JA, Niu Y, Fedorcsak P,
Huang CM, Li CJ, Vågbø CB, Shi Y, Wang WL, Song SH, et al: ALKBH5
is a mammalian RNA demethylase that impacts RNA metabolism and
mouse fertility. Mol Cell. 49:18–29. 2013. View Article : Google Scholar :
|
|
55
|
Aik W, Scotti JS, Choi H, Gong L,
Demetriades M, Schofield CJ and McDonough MA: Structure of human
RNA N6-methyladenine demethylase ALKBH5 provides insights into its
mechanisms of nucleic acid recognition and demethylation. Nucleic
Acids Res. 42:4741–4754. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang T, Kong S, Tao M and Ju S: The
potential role of RNA N6-methyladenosine in cancer progression. Mol
Cancer. 19:882020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang X, Zhao BS, Roundtree IA, Lu Z, Han
D, Ma H, Weng X, Chen K, Shi H and He C: N(6)-methyladenosine
modulates messenger RNA translation efficiency. Cell.
161:1388–1399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu T, Wei Q, Jin J, Luo Q, Liu Y, Yang Y,
Cheng C, Li L, Pi J, Si Y, et al: The m6A reader YTHDF1 promotes
ovarian cancer progression via augmenting EIF3C translation.
Nucleic Acids Res. 48:3816–3831. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang C, Chen L, Peng D, Jiang A, He Y,
Zeng Y, Xie C, Zhou H, Luo X, Liu H, et al: METTL3 and
N6-methyladenosine promote homologous recombination-mediated repair
of DSBs by modulating DNA-RNA hybrid accumulation. Mol Cell.
79:425–442.e7. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liu SY, Feng Y, Wu JJ, Zou ML, Sun ZL, Li
X and Yuan FL: m6A facilitates YTHDF-independent phase
separation. J Cell Mol Med. 24:2070–2072. 2020. View Article : Google Scholar
|
|
61
|
Ries RJ, Zaccara S, Klein P,
Olarerin-George A, Namkoong S, Pickering BF, Patil DP, Kwak H, Lee
JH and Jaffrey SR: m6A enhances the phase separation
potential of mRNA. Nature. 571:424–428. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gao Y, Pei G, Li D, Li R, Shao Y, Zhang QC
and Li P: Multivalent m6A motifs promote phase
separation of YTHDF proteins. Cell Res. 29:767–769. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang J, Wang L, Diao J, Shi YG, Shi Y, Ma
H and Shen H: Binding to m6A RNA promotes
YTHDF2-mediated phase separation. Protein Cell. 11:304–307. 2020.
View Article : Google Scholar
|
|
64
|
Sheth U and Parker R: Decapping and decay
of messenger RNA occur in cytoplasmic processing bodies. Science.
300:805–808. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M,
Ma J and Wu L: YTHDF2 destabilizes m(6)A-containing RNA through
direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun.
7:126262016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu
PJ, Liu C and He C: YTHDF3 facilitates translation and decay of
N6-methyladenosine-modified RNA. Cell Res. 27:315–328.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Xiao W, Adhikari S, Dahal U, Chen YS, Hao
YJ, Sun BF, Sun HY, Li A, Ping XL, Lai WY, et al: Nuclear m(6)A
reader YTHDC1 regulates mRNA splicing. Mol Cell. 61:507–519. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kasowitz SD, Ma J, Anderson SJ, Leu NA, Xu
Y, Gregory BD, Schultz RM and Wang PJ: Nuclear m6A reader YTHDC1
regulates alternative polyadenylation and splicing during mouse
oocyte development. PLoS Genet. 14. pp. e10074122018, View Article : Google Scholar
|
|
69
|
Roundtree IA, Luo GZ, Zhang Z, Wang X,
Zhou T, Cui Y, Sha J, Huang X, Guerrero L, Xie P, et al: YTHDC1
mediates nuclear export of N6-methyladenosine methylated
mRNAs. Elife. 6:e313112017. View Article : Google Scholar
|
|
70
|
Lesbirel S, Viphakone N, Parker M, Parker
J, Heath C, Sudbery I and Wilson SA: The m6A-methylase
complex recruits TREX and regulates mRNA export. Sci Rep.
8:138272018. View Article : Google Scholar
|
|
71
|
Brockdorff N, Bowness JS and Wei G:
Progress toward understanding chromosome silencing by Xist RNA.
Genes Dev. 34:733–744. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Liang D, Lin WJ, Ren M, Qiu J, Yang C,
Wang X, Li N, Zeng T, Sun K, You L, et al: m6A reader
YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin.
Autophagy. 18:1318–1337. 2022. View Article : Google Scholar
|
|
73
|
Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y,
Qi M, Lu Z, Shi H, Wang J, et al: Ythdc2 is an
N6-methyladenosine binding protein that regulates
mammalian spermatogenesis. Cell Res. 27:1115–1127. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
König J, Zarnack K, Rot G, Curk T, Kayikci
M, Zupan B, Turner DJ, Luscombe NM and Ule J: iCLIP reveals the
function of hnRNP particles in splicing at individual nucleotide
resolution. Nat Struct Mol Biol. 17:909–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
McCloskey A, Taniguchi I, Shinmyozu K and
Ohno M: hnRNP C tetramer measures RNA length to classify RNA
polymerase II transcripts for export. Science. 335:1643–1646. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Liu N, Dai Q, Zheng G, He C, Parisien M
and Pan T: N(6)-methyladenosine-dependent RNA structural switches
regulate RNA-protein interactions. Nature. 518:560–564. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhou KI, Shi H, Lyu R, Wylder AC, Matuszek
Ż, Pan JN, He C, Parisien M and Pan T: Regulation of
co-transcriptional pre-mRNA splicing by m6A through the
low-complexity protein hnRNPG. Mol Cell. 76:70–81.e9. 2019.
View Article : Google Scholar
|
|
78
|
Liu N, Zhou KI, Parisien M, Dai Q,
Diatchenko L and Pan T: N6-methyladenosine alters RNA structure to
regulate binding of a low-complexity protein. Nucleic Acids Res.
45:6051–6063. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Alarcón CR, Goodarzi H, Lee H, Liu X,
Tavazoie S and Tavazoie SF: HNRNPA2B1 is a mediator of
m(6)A-dependent nuclear RNA processing events. Cell. 162:1299–1308.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Fabbiano F, Corsi J, Gurrieri E, Trevisan
C, Notarangelo M and D'Agostino VG: RNA packaging into
extracellular vesicles: An orchestra of RNA-binding proteins? J
Extracell Vesicles. 10:e120432020. View Article : Google Scholar
|
|
81
|
Huang H, Weng H, Sun W, Qin X, Shi H, Wu
H, Zhao BS, Mesquita A, Liu C, Yuan CL, et al: Recognition of RNA
N6-methyladenosine by IGF2BP proteins enhances mRNA
stability and translation. Nat Cell Biol. 20:285–295. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wu Z, Shi Y, Lu M, Song M, Yu Z, Wang J,
Wang S, Ren J, Yang YG, Liu GH, et al: METTL3 counteracts premature
aging via m6A-dependent stabilization of MIS12 mRNA. Nucleic Acids
Res. 48:11083–11096. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Edupuganti RR, Geiger S, Lindeboom RGH,
Shi H, Hsu PJ, Lu Z, Wang SY, Baltissen MPA, Jansen PWTC, Rossa M,
et al: N6-methyladenosine (m6A) recruits and
repels proteins to regulate mRNA homeostasis. Nat Struct Mol Biol.
24:870–878. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhang J, Bai R, Li M, Ye H, Wu C, Wang C,
Li S, Tan L, Mai D, Li G, et al: Excessive miR-25-3p maturation via
N6-methyladenosine stimulated by cigarette smoke promotes
pancreatic cancer progression. Nat Commun. 10:18582019. View Article : Google Scholar :
|
|
85
|
Hua YQ, Zhang K, Sheng J, Ning ZY, Li Y,
Shi WD and Liu LM: NUCB1 suppresses growth and shows additive
effects with gemcitabine in pancreatic ductal adenocarcinoma via
the unfolded protein response. Front Cell Dev Biol. 9:6418362021.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Wang M, Liu J, Zhao Y, He R, Xu X, Guo X,
Li X, Xu S, Miao J, Guo J, et al: Upregulation of METTL14 mediates
the elevation of PERP mRNA N6 adenosine methylation
promoting the growth and metastasis of pancreatic cancer. Mol
Cancer. 19:1302020. View Article : Google Scholar
|
|
87
|
Xie F, Liu S and Wang H: M6A
methyltransferase METTL16 suppresses pancreatic cancer
proliferation through p21 pathways. Pancreas. 49:14372020.
|
|
88
|
Huang H, Li H, Pan R, Wang S, Khan AA,
Zhao Y, Zhu H and Liu X: Ribosome 18S m6A
methyltransferase METTL5 promotes pancreatic cancer progression by
modulating c-Myc translation. Int J Oncol. 60:92022. View Article : Google Scholar
|
|
89
|
Zeng J, Zhang H, Tan Y, Wang Z, Li Y and
Yang X: m6A demethylase FTO suppresses pancreatic cancer
tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.
Mol Ther Nucleic Acids. 25:277–292. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Tang X, Liu S, Chen D, Zhao Z and Zhou J:
The role of the fat mass and obesity-associated protein in the
proliferation of pancreatic cancer cells. Oncol Lett. 17:2473–2478.
2019.PubMed/NCBI
|
|
91
|
Guo X, Li K, Jiang W, Hu Y, Xiao W, Huang
Y, Feng Y, Pan Q and Wan R: RNA demethylase ALKBH5 prevents
pancreatic cancer progression by posttranscriptional activation of
PER1 in an m6A-YTHDF2-dependent manner. Mol Cancer. 19:912020.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
He Y, Hu H, Wang Y, Yuan H, Lu Z, Wu P,
Liu D, Tian L, Yin J, Jiang K and Miao Y: ALKBH5 inhibits
pancreatic cancer motility by decreasing long non-coding RNA
KCNK15-AS1 methylation. Cell Physiol Biochem. 48:838–846. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
He Y, Yue H, Cheng Y, Ding Z, Xu Z, Lv C,
Wang Z, Wang J, Yin C, Hao H and Chen C: ALKBH5-mediated
m6A demethylation of KCNK15-AS1 inhibits pancreatic
cancer progression via regulating KCNK15 and PTEN/AKT signaling.
Cell Death Dis. 12:11212021. View Article : Google Scholar
|
|
94
|
Tang B, Yang Y, Kang M, Wang Y, Wang Y, Bi
Y, He S and Shimamoto F: m6A demethylase ALKBH5 inhibits
pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation
and mediating Wnt signaling. Mol Cancer. 19:32020. View Article : Google Scholar
|
|
95
|
Huang R, Yang L, Zhang Z, Liu X, Fei Y,
Tong WM, Niu Y and Liang Z: RNA m6A demethylase ALKBH5
protects against pancreatic ductal adenocarcinoma via targeting
regulators of iron metabolism. Front Cell Dev Biol. 9:7242822021.
View Article : Google Scholar
|
|
96
|
Hu X, Peng WX, Zhou H, Jiang J, Zhou X,
Huang D, Mo YY and Yang L: IGF2BP2 regulates DANCR by serving as an
N6-methyladenosine reader. Cell Death Differ. 27:1782–1794. 2020.
View Article : Google Scholar :
|
|
97
|
Meng X, Deng Y, He S, Niu L and Zhu H:
m6A-mediated upregulation of LINC00857 promotes
pancreatic cancer tumorigenesis by regulating the miR-150-5p/E2F3
axis. Front Oncol. 11:6299472021. View Article : Google Scholar
|
|
98
|
Zhai S, Xu Z, Xie J, Zhang J, Wang X, Peng
C, Li H, Chen H, Shen B and Deng X: Epigenetic silencing of LncRNA
LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating
miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1. Oncogene.
40:277–291. 2021. View Article : Google Scholar :
|
|
99
|
Geng Y, Guan R, Hong W, Huang B, Liu P,
Guo X, Hu S, Yu M and Hou B: Identification of m6A-related genes
and m6A RNA methylation regulators in pancreatic cancer and their
association with survival. Ann Transl Med. 8:3872020. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ying P, Li Y, Yang N, Wang X, Wang H, He
H, Li B, Peng X, Zou D, Zhu Y, et al: Identification of genetic
variants in m6A modification genes associated with
pancreatic cancer risk in the Chinese population. Arch Toxicol.
95:1117–1128. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Tian J, Zhu Y, Rao M, Cai Y, Lu Z, Zou D,
Peng X, Ying P, Zhang M, Niu S, et al:
N6-methyladenosine mRNA methylation of PIK3CB regulates
AKT signalling to promote PTEN-deficient pancreatic cancer
progression. Gut. 69:2180–2192. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Xia T, Wu X, Cao M, Zhang P, Shi G, Zhang
J, Lu Z, Wu P, Cai B, Miao Y and Jiang K: The RNA m6A
methyltransferase METTL3 promotes pancreatic cancer cell
proliferation and invasion. Pathol Res Pract. 215:1526662019.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Li BQ, Huang S, Shao QQ, Sun J, Zhou L,
You L, Zhang TP, Liao Q, Guo JC and Zhao YP: WT1-associated protein
is a novel prognostic factor in pancreatic ductal adenocarcinoma.
Oncol Lett. 13:2531–2538. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Chen J, Sun Y, Xu X, Wang D, He J, Zhou H,
Lu Y, Zeng J, Du F, Gong A and Xu M: YTH domain family 2
orchestrates epithelial-mesenchymal transition/proliferation
dichotomy in pancreatic cancer cells. Cell Cycle. 16:2259–2271.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Dai S, Zhang J, Huang S, Lou B, Fang B, Ye
T, Huang X, Chen B and Zhou M: HNRNPA2B1 regulates the
epithelial-mesenchymal transition in pancreatic cancer cells
through the ERK/snail signalling pathway. Cancer Cell Int.
17:122017. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Dahlem C, Barghash A, Puchas P, Haybaeck J
and Kessler SM: The insulin-like growth factor 2 mRNA binding
protein IMP2/IGF2BP2 is overexpressed and correlates with poor
survival in pancreatic cancer. Int J Mol Sci. 20:32042019.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Chen S, Yang C, Wang ZW, Hu JF, Pan JJ,
Liao CY, Zhang JQ, Chen JZ, Huang Y, Huang L, et al: CLK1/SRSF5
pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and
promotes growth and metastasis of pancreatic cancer. J Hematol
Oncol. 14:602021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Huang XT, Li JH, Zhu XX, Huang CS, Gao ZX,
Xu QC, Zhao W and Yin XY: HNRNPC impedes m6A-dependent
anti-metastatic alternative splicing events in pancreatic ductal
adenocarcinoma. Cancer Lett. 518:196–206. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Hu Y, Tang J, Xu F, Chen J, Zeng Z, Han S,
Wang F, Wang D, Huang M, Zhao Y, et al: A reciprocal feedback
between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1
promotes glycolysis of pancreatic cancer through inhibiting
maturation of miR-5586-5p. J Exp Clin Cancer Res. 41:692022.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Huang S, Wu Z, Cheng Y, Wei W and Hao L:
Insulin-like growth factor 2 mRNA binding protein 2 promotes
aerobic glycolysis and cell proliferation in pancreatic ductal
adenocarcinoma via stabilizing GLUT1 mRNA. Acta Biochim Biophys Sin
(Shanghai). 51:743–752. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Taketo K, Konno M, Asai A, Koseki J,
Toratani M, Satoh T, Doki Y, Mori M, Ishii H and Ogawa K: The
epitranscriptome m6A writer METTL3 promotes chemo- and
radioresistance in pancreatic cancer cells. Int J Oncol.
52:621–629. 2018.PubMed/NCBI
|
|
113
|
Zhang C, Ou S, Zhou Y, Liu P, Zhang P, Li
Z, Xu R and Li Y: m6A methyltransferase METTL14-mediated
upregulation of cytidine deaminase promoting gemcitabine resistance
in pancreatic cancer. Front Oncol. 11:6963712021. View Article : Google Scholar
|
|
114
|
Kong F, Liu X, Zhou Y, Hou X, He J, Li Q,
Miao X and Yang L: Downregulation of METTL14 increases apoptosis
and autophagy induced by cisplatin in pancreatic cancer cells. Int
J Biochem Cell Biol. 122:1057312020. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Chen B, Ye F, Yu L, Jia G, Huang X, Zhang
X, Peng S, Chen K, Wang M, Gong S, et al: Development of
cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am
Chem Soc. 134:17963–17971. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun
L, Wang Y, Li X, Xiong XF, Wei B, et al: RNA N6-methyladenosine
demethylase FTO promotes breast tumor progression through
inhibiting BNIP3. Mol Cancer. 18:462019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Huang Y, Yan J, Li Q, Li J, Gong S, Zhou
H, Gan J, Jiang H, Jia GF, Luo C and Yang CG: Meclofenamic acid
selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic
Acids Res. 43:373–384. 2015. View Article : Google Scholar :
|
|
118
|
Cui Q, Shi H, Ye P, Li L, Qu Q, Sun G, Sun
G, Lu Z, Huang Y, Yang CG, et al: m6A RNA methylation
regulates the self-renewal and tumorigenesis of glioblastoma stem
cells. Cell Rep. 18:2622–2634. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu
H, Ni T, Zhang ZS, Zhang T, Li C, et al: Small-molecule targeting
of oncogenic FTO demethylase in acute myeloid leukemia. Cancer
Cell. 35:677–691.e10. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Su R, Dong L, Li C, Nachtergaele S,
Wunderlich M, Qing Y, Deng X, Wang Y, Weng X, Hu C, et al: R-2HG
exhibits anti-tumor activity by targeting
FTO/m6A/MYC/CEBPA signaling. Cell. 172:90–105.e23. 2018.
View Article : Google Scholar
|
|
121
|
Xu P and Ge R: Roles and drug development
of METTL3 (methyltransferase-like 3) in anti-tumor therapy. Eur J
Med Chem. 230:1141182022. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Forino NM, Hentschel J and Stone MD:
Cryo-EM structures tell a tale of two telomerases. Nat Struct Mol
Biol. 28:457–459. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Yankova E, Blackaby W, Albertella M, Rak
J, De Braekeleer E, Tsagkogeorga G, Pilka ES, Aspris D, Leggate D,
Hendrick AG, et al: Small-molecule inhibition of METTL3 as a
strategy against myeloid leukaemia. Nature. 593:597–601. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Weng H, Huang H, Wu H, Qin X, Zhao BS,
Dong L, Shi H, Skibbe J, Shen C, Hu C, et al: METTL14 inhibits
hematopoietic stem/progenitor differentiation and promotes
leukemogenesis via mRNA m6A modification. Cell Stem
Cell. 22:191–205.e9. 2018. View Article : Google Scholar
|
|
125
|
Zhang J, Tsoi H, Li X, Wang H, Gao J, Wang
K, Go MY, Ng SC, Chan FK, Sung JJ and Yu J: Carbonic anhydrase IV
inhibits colon cancer development by inhibiting the Wnt signalling
pathway through targeting the WTAP-WT1-TBL1 axis. Gut.
65:1482–1493. 2016. View Article : Google Scholar
|
|
126
|
Huang C, Zhou S, Zhang C, Jin Y, Xu G,
Zhou L, Ding G, Pang T, Jia S and Cao L: ZC3H13-mediated
N6-methyladenosine modification of PHF10 is impaired by fisetin
which inhibits the DNA damage response in pancreatic cancer. Cancer
Lett. 530:16–28. 2022. View Article : Google Scholar : PubMed/NCBI
|
